CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) today released its financial results for the three and nine months ended...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No...
OMB APPROVAL OMB Number: 3235-0145 Expires: Estimated average burden hours per response...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment) NAME...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities & Exchange Act of 1934 (Amendment...
NEW YORK, Feb. 13, 2012 (GLOBE NEWSWIRE) -- Shareholders of China Medical Technologies, Inc. ("China Medical" or the "Company") (Nasdaq:CMED) are...
Notice is hereby given that Glancy Binkow & Goldberg LLP has filed a class action lawsuit in the United States District Court for...
NEW YORK, Feb. 8, 2012 (GLOBE NEWSWIRE) -- Shareholders of China Medical Technologies, Inc. ("China Medical" or the "Company") (Nasdaq:CMED) are...
NEW YORK, Feb. 7, 2012 (GLOBE NEWSWIRE) -- The NASDAQ Stock Market® (Nasdaq:NDAQ) announced that trading was...
Faruqi & Faruqi, LLP Files Securities Class Action Suit Against China Medical Technologies, Inc. and Certain of Its Executives PR Newswire NEW...
DENVER, CO -- (Marketwire) -- 02/02/12 -- Dyer & Berens LLP (www.DyerBerens.com) today announced that a class action lawsuit has been filed in the...
NEW YORK, Jan. 27, 2012 (GLOBE NEWSWIRE) -- Shareholders of China Medical Technologies, Inc. ("China Medical" or the "Company") (Nasdaq:CMED) are...
NEW YORK, Jan. 13, 2012 (GLOBE NEWSWIRE) -- Shareholders of China Medical Technologies, Inc. ("China Medical" or the "Company") (Nasdaq:CMED) are...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.